HTB news: Early reports from CROI…
21 February 2026. Related: News.
February news – January news – December news – All back issues
Recent HTB highlights
Early reposts from this years conference being held in Denver.
Three papers on HPV and anal cancer include finding high rates of HSIL in HIV negative gay men on PrEP.
An analysis in Lancet Public Health calculates an additional 23 million deaths by 2030 in low income countries due to changes in global health policies last year.
Results from surveys in two small cure-related studies show that the anxiety related to having to stop ART should perhaps also be studied.
Gilead plans to withdraw this PK booster by the end of 2026 due to low use. All fixed dose combinations that include cobicistat will continue to be available,
Two recent studies looking to explain how PrEP works suggest easier dosing might be possible for women and transgender and non-binary people or when the risk is from shared injecting rather than from sex. This special report looks at the differences between PrEP guidelines and why this is an activist issue in 2026.
All reports
Subscribe to HTB by email to receive the latest news every 3-4 weeks.
Reports will also be posted to social media.
Twitter (X) – Bluesky – Facebook – Instagram